Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FJEGG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,174
Award facts
- Contract value 100% obligated
- $49,173.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, valued at $49,173.87, is scheduled for completion by September 19, 2025, and will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating it was competitively awarded through open procurement processes. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors and healthcare solutions providers, maintains a substantial federal contract portfolio primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's capability to supply a diverse range of pharmaceutical products—including brand-name medications, generics, vaccines, and specialized medical supplies across multiple therapeutic domains—supports critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order exemplifies the company's role as a key vendor in the federal medical procurement landscape, providing essential pharmaceutical commodities to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FJEGG?
SPE2DB25FJEGG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FJEGG worth?
The government has obligated $49,174 on SPE2DB25FJEGG.
Is contract SPE2DB25FJEGG an order under another contract?
Yes. SPE2DB25FJEGG is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB25FJEGG competed?
The extent of competition for SPE2DB25FJEGG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award